ID: ALA522813

Max Phase: Preclinical

Molecular Formula: C25H26ClNO9

Molecular Weight: 519.93

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)c(CC(=O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O)c(C)n2C(=O)c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C25H26ClNO9/c1-12-16(10-20(28)35-11-19-21(29)22(30)23(31)25(33)36-19)17-9-15(34-2)7-8-18(17)27(12)24(32)13-3-5-14(26)6-4-13/h3-9,19,21-23,25,29-31,33H,10-11H2,1-2H3/t19-,21-,22+,23-,25-/m1/s1

Standard InChI Key:  KURMVZVFDHBCQJ-FGBFUVBKSA-N

Associated Targets(non-human)

Solute carrier family 2, facilitated glucose transporter member 1 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4256 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 519.93Molecular Weight (Monoisotopic): 519.1296AlogP: 1.19#Rotatable Bonds: 6
Polar Surface Area: 147.68Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: CX LogP: 1.26CX LogD: 1.26
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.35Np Likeness Score: 0.26

References

1. Gynther M, Ropponen J, Laine K, Leppänen J, Haapakoski P, Peura L, Järvinen T, Rautio J..  (2009)  Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.,  52  (10): [PMID:19402664] [10.1021/jm8015409]

Source